Wellington Management Group LLP Buys 123,056 Shares of LifeStance Health Group, Inc. $LFST

Key Points

• Wellington Management Group LLP increased its stake in LifeStance Health Group by 2.3%, acquiring an additional 123,056 shares during the first quarter, bringing their total ownership to approximately $35.96 million.
• Major shareholder Summit Partners L.P. sold 8,407,643 shares, representing a 20.05% decrease in their holdings, valued at over $42.6 million.
• Recent earnings reports showed that LifeStance Health Group topped analysts' expectations with a revenue of $345.31 million, marking a 10.6% increase year-over-year.

Wellington Management Group LLP grew its stake in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 2.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 5,399,293 shares of the company's stock after acquiring an additional 123,056 shares during the quarter. Wellington Management Group LLP owned 1.39% of LifeStance Health Group worth $35,959,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of LFST. Parcion Private Wealth LLC bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at about $15,670,000. Dimensional Fund Advisors LP increased its stake in shares of LifeStance Health Group by 87.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock valued at $25,977,000 after acquiring an additional 1,643,390 shares during the last quarter. Nuveen LLC bought a new stake in shares of LifeStance Health Group in the 1st quarter valued at about $6,928,000. First Trust Advisors LP bought a new stake in shares of LifeStance Health Group in the 4th quarter valued at about $4,535,000. Finally, Vanguard Group Inc. increased its stake in shares of LifeStance Health Group by 5.0% in the 1st quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock valued at $74,733,000 after acquiring an additional 531,841 shares during the last quarter. 85.50% of the stock is owned by institutional investors.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, major shareholder Summit Partners L. P sold 8,407,643 shares of the company's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the insider owned 33,524,715 shares of the company's stock, valued at $169,970,305.05. This represents a 20.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Darren M. Black sold 8,407,643 shares of the company's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $5.07, for a total value of $42,626,750.01. Following the transaction, the director directly owned 33,524,715 shares of the company's stock, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 20,423,643 shares of company stock worth $103,561,790. Insiders own 6.60% of the company's stock.

LifeStance Health Group Price Performance

Shares of LFST opened at $5.55 on Monday. LifeStance Health Group, Inc. has a 52-week low of $3.74 and a 52-week high of $8.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.48 and a current ratio of 1.48. The stock has a 50 day simple moving average of $4.67 and a 200 day simple moving average of $5.98. The firm has a market capitalization of $2.16 billion, a PE ratio of -111.00 and a beta of 1.13.

LifeStance Health Group (NASDAQ:LFST - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.03) by $0.02. LifeStance Health Group had a negative return on equity of 1.11% and a negative net margin of 1.23%.The firm had revenue of $345.31 million during the quarter, compared to the consensus estimate of $345.05 million. During the same quarter in the prior year, the firm posted ($0.06) EPS. The business's revenue was up 10.6% on a year-over-year basis. LifeStance Health Group has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Sell-side analysts predict that LifeStance Health Group, Inc. will post -0.18 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on LFST shares. BTIG Research began coverage on LifeStance Health Group in a research note on Friday, July 25th. They issued a "buy" rating and a $8.00 price target for the company. UBS Group boosted their price objective on LifeStance Health Group from $8.50 to $9.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Finally, Wall Street Zen upgraded LifeStance Health Group from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, LifeStance Health Group presently has a consensus rating of "Moderate Buy" and a consensus price target of $8.50.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.

Want to see what other hedge funds are holding LFST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.